Lo mejor de Main Arena

PCI-Advances in DIABETIC PATIENTS – MIL & WIN SESSION – SOLACI-SOCIME 2022

solaci
solaci
238
0
Previous article
PCI-Advances in DIABETIC PATIENTS – MIL & WIN SESSION – SOLACI-SOCIME 2022
Next article
PCI-Advances in DIABETIC PATIENTS – MIL & WIN SESSION – SOLACI-SOCIME 2022
solaci
solaci

More articles by this author

Advances in Structural Intervention – SOLACI-SOCIME 2022

solaci - 0
✔️ Advances in Structural Intervention - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 - Palabras de Bienvenida - Dr. Guering Eid-Lidt (MEX)...

Endovascular Treatment of Femoropopliteal Segment – SOLACI-SOCIME 2022

solaci - 0
✔️ Endovascular Treatment of Femoropopliteal Segment - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 - How Palabras de bienvenida - Dr. Luis Virgen...

Pulmonary Valve – SOLACI-SOCIME 2022

solaci - 0
✔️ Pulmonary Valve - SOLACI-SOCIME 2022 ✔️ SOLACI-SOCIME 2022 Scientific Sessions 👨‍🏫 Contents: 00:10 - How to select the type of THV in pulmonary valve...

Complex PCI: Distal Left Main Coronary Artery – SOLACI-SOCIME 2022

solaci - 0
✔️ Complex PCI: Distal Left Main Coronary Artery - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session.  👨‍🏫 Contents: 00:13 - Welcoming words - Dr. Álvaro...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

The Best of Main Arena

Advances in Structural Intervention – SOLACI-SOCIME 2022

✔️ Advances in Structural Intervention - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 - Palabras de Bienvenida -...
solaci -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Dr. Juan Manuel Pérez - 0
Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Dr. Juan Manuel Pérez - 0
Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

Dr. Andrés Rodríguez - 0
The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...